Anonymous ID: 5ca2f7 Dec. 23, 2022, 4:51 p.m. No.18005648   ๐Ÿ—„๏ธ.is ๐Ÿ”—kun   >>5702 >>5778

FDA Approves Monoclonal Antibody To Treat COVID-19 For First Time

 

https://twitter.com/zerohedge/status/1606450871121969154

 

Healthcare company Rocheโ€™s Actemra (tocilizumab) intravenous (IV) was approved by the FDA to treat severe COVID-19 in adults, the company announced on Wednesday.

 

Specifically, the drug is approved in cases where the patient is hospitalized and is receiving systemic corticosteroids, as well as requiring supplemental oxygen, non-invasive or invasive mechanical ventilation, or extracorporeal membrane oxygenation.

 

It is the first FDA-approved monoclonal antibody to treat COVID-19, the company stated.

 

Monoclonal antibodies are laboratory-created proteins that mimic natural antibodies the body produces to fight off harmful pathogens, such as the SARS-CoV-2 virus that causes COVID-19.

 

Actemra does not directly target SARS-CoV-2 but addresses the inflammation that occurs from COVID-19 infection. The monoclonal antibody reduces inflammation by blocking the interleukin-6 receptor.

 

The drug is recommended to be administered as a single 60-minute IV infusion.